Search research articles
Contact Us
Filters
Showing results (91-100 of 377) with videos related to
Page
of 38
Sort By:
The Biochemical Journal
|
March 15, 1987
Activation of adenylate cyclase in human platelet membranes by guanosine 5'-[beta gamma-imido]triphosphate is inhibited by cyclic-AMP-dependent phosphorylation. Slow activation occurs in the absence of ATP
R W Farndale, S K Wong, B R Martin
Life Sciences
|
January 1, 1990
Affinity of the enantiomers of alpha- and beta-cyclazocine for binding to the phencyclidine and mu opioid receptors
S L Todd, R L Balster, B R Martin
The Journal of Pharmacology and Experimental Therapeutics
|
June 1, 1990
Pharmacological characterization of cannabinoids in the elevated plus maze
E S Onaivi, M R Green, B R Martin
Biochemical and Biophysical Research Communications
|
June 15, 1990
Insulin alters the target size of the peripheral cyclic AMP phosphodiesterase but not the integral cyclic GMP-stimulated cyclic AMP phosphodiesterase in liver plasma membranes
A V Wallace, B R Martin, M D Houslay
Advances in Alcohol & Substance Abuse
|
January 1, 1990
Cannabis dependence and tolerance production
D R Compton, W L Dewey, B R Martin
The Journal of Pharmacology and Experimental Therapeutics
|
September 19, 2000
Bupropion is a nicotinic antagonist
J E Slemmer, B R Martin, M I Damaj
Life Sciences
|
April 3, 1978
Evidence for the existence of specific cannabinoid binding sites
L S Harris, R A Carchman, B R Martin
Biochemical Pharmacology
|
March 8, 1996
Anandamide- and delta9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4 -methyl-1H-pyrazole-3-carboximide hydrochloride]
A C Shivachar, B R Martin, E F Ellis
The Journal of Pharmacy and Pharmacology
|
August 1, 1977
Identification of metabolites of delta1- and delta1(6)-tetrahydrocannabinol containing a reduced double bond
D J Harvey, B R Martin, W D Paton
Brain Research
|
January 8, 1996
Cannabinoid receptor down-regulation without alteration of the inhibitory effect of CP 55,940 on adenylyl cyclase in the cerebellum of CP 55,940-tolerant mice
F Fan, Q Tao, M Abood, et al.
Page
of 38
Search research articles
Search
Showing results (91-100 of 377) with videos related to
Sort By:
Page
of 38
The Biochemical Journal
|
March 15, 1987
Activation of adenylate cyclase in human platelet membranes by guanosine 5'-[beta gamma-imido]triphosphate is inhibited by cyclic-AMP-dependent phosphorylation. Slow activation occurs in the absence of ATP
R W Farndale, S K Wong, B R Martin
Life Sciences
|
January 1, 1990
Affinity of the enantiomers of alpha- and beta-cyclazocine for binding to the phencyclidine and mu opioid receptors
S L Todd, R L Balster, B R Martin
The Journal of Pharmacology and Experimental Therapeutics
|
June 1, 1990
Pharmacological characterization of cannabinoids in the elevated plus maze
E S Onaivi, M R Green, B R Martin
Biochemical and Biophysical Research Communications
|
June 15, 1990
Insulin alters the target size of the peripheral cyclic AMP phosphodiesterase but not the integral cyclic GMP-stimulated cyclic AMP phosphodiesterase in liver plasma membranes
A V Wallace, B R Martin, M D Houslay
Advances in Alcohol & Substance Abuse
|
January 1, 1990
Cannabis dependence and tolerance production
D R Compton, W L Dewey, B R Martin
The Journal of Pharmacology and Experimental Therapeutics
|
September 19, 2000
Bupropion is a nicotinic antagonist
J E Slemmer, B R Martin, M I Damaj
Life Sciences
|
April 3, 1978
Evidence for the existence of specific cannabinoid binding sites
L S Harris, R A Carchman, B R Martin
Biochemical Pharmacology
|
March 8, 1996
Anandamide- and delta9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4 -methyl-1H-pyrazole-3-carboximide hydrochloride]
A C Shivachar, B R Martin, E F Ellis
The Journal of Pharmacy and Pharmacology
|
August 1, 1977
Identification of metabolites of delta1- and delta1(6)-tetrahydrocannabinol containing a reduced double bond
D J Harvey, B R Martin, W D Paton
Brain Research
|
January 8, 1996
Cannabinoid receptor down-regulation without alteration of the inhibitory effect of CP 55,940 on adenylyl cyclase in the cerebellum of CP 55,940-tolerant mice
F Fan, Q Tao, M Abood, et al.
Page
of 38